New Zealand markets open in 4 hours 54 minutes

Coloplast A/S (0QBO.IL)

IOB - IOB Delayed price. Currency in DKK
Add to watchlist
845.00+7.40 (+0.88%)
At close: 05:37PM BST
Currency in DKK

Valuation measures4

Market cap (intra-day) 188.04B
Enterprise value 208.76B
Trailing P/E 37.59
Forward P/E 34.48
PEG ratio (5-yr expected) 3.21
Price/sales (ttm)7.27
Price/book (mrq)12.45
Enterprise value/revenue 8.35
Enterprise value/EBITDA 26.23

Trading information

Stock price history

Beta (5Y monthly) 0.26
52-week change 3-14.08%
S&P500 52-week change 323.57%
52-week high 3984.80
52-week low 3689.60
50-day moving average 3917.69
200-day moving average 3813.26

Share statistics

Avg vol (3-month) 391.66k
Avg vol (10-day) 329.11k
Shares outstanding 5206.51M
Implied shares outstanding 6231.22M
Float 8134.44M
% held by insiders 135.90%
% held by institutions 127.40%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 420
Forward annual dividend yield 42.76%
Trailing annual dividend rate 320.00
Trailing annual dividend yield 32.39%
5-year average dividend yield 4N/A
Payout ratio 488.81%
Dividend date 3N/A
Ex-dividend date 415 May 2023
Last split factor 25:1
Last split date 319 Dec 2012

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 19.66%
Operating margin (ttm)28.64%

Management effectiveness

Return on assets (ttm)12.40%
Return on equity (ttm)69.51%

Income statement

Revenue (ttm)24.33B
Revenue per share (ttm)114.59
Quarterly revenue growth (yoy)4.40%
Gross profit (ttm)15.53B
EBITDA 7.71B
Net income avi to common (ttm)4.78B
Diluted EPS (ttm)22.50
Quarterly earnings growth (yoy)-1.30%

Balance sheet

Total cash (mrq)855M
Total cash per share (mrq)4.02
Total debt (mrq)22.12B
Total debt/equity (mrq)340.76%
Current ratio (mrq)0.98
Book value per share (mrq)30.55

Cash flow statement

Operating cash flow (ttm)4.49B
Levered free cash flow (ttm)2.74B